Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Phenotypic and genetic characteristics of patients with type 2 diabetes with different responses to metformin therapy in Novosibirsk region

Aim: The purpose of this study was to examine the phenotypic and genetic characteristics of patients with type 2 diabetes mellitus (T2DM) with different responses to treatment with metformin (MF) in the Novosibirsk region. Materials and methods: We examined 460 patients with T2DM in the Novosibirsk...

Full description

Bibliographic Details
Main Authors:	Irina A. Bondar, Olesya Y. Shabelnikova, Ekaterina A. Sokolova, Olga V. Pyankova, Maksim L. Filipenko
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2016-05-01
Series:	Сахарный диабет
Subjects:	type 2 diabetes mellitus metformin atm (rs11212617).
Online Access:	https://www.dia-endojournals.ru/jour/article/view/7227

Similar Items

Factors associated with abnormal cardio-ankle vascular index in patients with type 2 diabetes and prediabetes
by: Aleksei N. Sumin, et al.
Published: (2016-05-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
by: Elisabet Cuyàs, et al.
Published: (2019-03-01)

Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
by: Irina Arkad'evna Bondar, et al.
Published: (2015-03-01)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)

Type 2 diabetes clusters in the Novosibirsk region
by: I. A. Bondar, et al.
Published: (2023-07-01)

Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis.
by: Ekaterina Alekseevna Sokolova, et al.
Published: (2015-01-01)

Advantages of the use of metformin in patients with impaired uric acid metabolism
by: Maksim S. Eliseev, et al.
Published: (2021-05-01)

Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01)

Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017-08-01)

Preparation of One of Metformin Derivatives and Study Its Effect on Some Biochemical Parameters in Blood Sera of Rabbits
by: Firas Sh. Abdul- Razzak, et al.
Published: (2017-04-01)

Metformin versus insulin in the management of gestational diabetes mellitus
by: Ola Amer Mahmood
Published: (2019-01-01)

Research Advance in Anti-lung Cancer Mechanism of Metformin
by: Gaoxiang WANG, et al.
Published: (2020-04-01)

In‐Depth Evaluation of MiRS Total Precipitable Water From NOAA‐20 ATMS Using Multiple Reference Data Sets
by: Yong‐Keun Lee, et al.
Published: (2022-02-01)

Efficacy of metformin and insulin in the management of gestational diabetes mellitus: A comparative study
by: Anupama Marnal B. A, et al.
Published: (2023-07-01)

Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)

Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
by: Santosh Kumar Singh, et al.
Published: (2021-08-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
by: Chin‐Hsiao Tseng
Published: (2018-07-01)

Effect of Metformin on Diabetes Mellitus Prevention in Pregnant Women with Risk Factors
by: Shirin Niroomanesh, et al.
Published: (2010-12-01)

Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus
by: Yulia A. Nasykhova, et al.
Published: (2022-07-01)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
by: Anna I. Sazonova, et al.
Published: (2016-05-01)

The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients
by: Yung-An Tsou, et al.
Published: (2019-08-01)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
by: Guoli Du, et al.
Published: (2020-10-01)

Metformin Role in Diabetic Patients with Tuberculosis: a Review
by: Esravila Ariya Wibisono
Published: (2021-06-01)

Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy
by: Wai-Shan Chung, et al.
Published: (2020-07-01)

Metformin – a possible way to reduce risk and improve oncological outcome of cervical cancer
by: Jitti Hanprasertpong
Published: (2016-09-01)

Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital
by: Chia‐Po Fu, et al.
Published: (2021-09-01)

Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study
by: Eunki Chung, et al.
Published: (2024-03-01)

The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2
by: Vuković Mira, et al.
Published: (2007-01-01)

Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
by: A. M. Mkrtumyan
Published: (2018-03-01)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
by: Hyun Hee Chung, et al.
Published: (2013-04-01)

ASSOCIATION OF VITAMIN B12 DEFICIENCY AND METFORMIN USE IN PATIENTS PRESENTING WITH TYPE II DIABETES MELLITUS
by: Karamat Ali, et al.
Published: (2020-10-01)

Metformin and Bee Venom Enhanced Histological Changes of the Pancreas in Diabetic Mice
by: Rana, et al.
Published: (2022-09-01)

Gallic acid improves the metformin effects on diabetic kidney disease in mice
by: Yan Hong, et al.
Published: (2023-12-01)

Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
by: Willian Barbosa Sales, et al.
Published: (2018-04-01)

Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
by: M. Tarbiat, et al.
Published: (2016-09-01)

The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
by: Stavros P. Papadakos, et al.
Published: (2023-06-01)

Physiological disturbances and histological damages of reproductive system in male rats resulted by metformin
by: Fatima Aziz Mahdi Al-badry
Published: (2022-10-01)

Genetic framework of type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)